Ascus Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Ascus Biosciences's estimated annual revenue is currently $11.9M per year.
- Ascus Biosciences's estimated revenue per employee is $155,000
- Ascus Biosciences's total funding is $51M.
Employee Data
- Ascus Biosciences has 77 Employees.
- Ascus Biosciences grew their employee count by 13% last year.
Ascus Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Research Associate | Reveal Email/Phone |
Ascus Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ascus Biosciences?
The mission at Ascus Biosciences is better microbes for a better life. Based in San Diego, CA, Ascus is focused on discovering, developing, and commercializing first-in-class endomicrobial products for the animal health and nutrition industries. Founded in 2015, Ascus is pioneering the emerging science of endomicrobial ecology to illuminate microbial communities within animals, and the role they play in overall health and performance. Ascus has a broad pipeline of all-natural, endomicrobial products in development across livestock and companion animals.
keywords:N/A
$51M
Total Funding
77
Number of Employees
$11.9M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ascus Biosciences News
Ascus uses its proprietary technology platform to resolve the complexities in the native microbial communities living in highly productive and...
Ascus Biosciences is looking to translate research focused on sampling and identifying communities of microbes in the rumen of high...
Premium Singapore state investor Temasek has led the $46-million Series B funding in Ascus Biosciences, a US-based deep science animal health and nutrition company that develops various microbial solutions. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already ...
San Diego-based Ascus Biosciences, a developer of feed supplements for animal health and nutrition, said this week that it has raised $46M in a Series B funding round. THe funding was led by Temasek Holdings, and also included Anterra Capital, Formation 8, and Cavallo Ventures (venture capital a ...
Premium Singapore state investor Temasek has led the $46-million Series B funding in Ascus Biosciences, a US-based deep science animal health and nutrition company that develops various microbial solutions. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10M | 77 | -5% | $349.8M |
#2 | $20.8M | 77 | -17% | N/A |
#3 | $11.9M | 77 | 10% | $61.2M |
#4 | $10.8M | 77 | -32% | N/A |
#5 | $11.9M | 77 | 15% | N/A |